Kurylcio, A.; Pelc, Z.; Skórzewska, M.; Rawicz-Pruszyński, K.; Mlak, R.; Gęca, K.; Sędłak, K.; Kurylcio, P.; Małecka-Massalska, T.; Polkowski, W.
Superparamagnetic Iron Oxide for Identifying Sentinel Lymph Node in Breast Cancer after Neoadjuvant Chemotherapy: Feasibility Study. J. Clin. Med. 2021, 10, 3149.
https://doi.org/10.3390/jcm10143149
AMA Style
Kurylcio A, Pelc Z, Skórzewska M, Rawicz-Pruszyński K, Mlak R, Gęca K, Sędłak K, Kurylcio P, Małecka-Massalska T, Polkowski W.
Superparamagnetic Iron Oxide for Identifying Sentinel Lymph Node in Breast Cancer after Neoadjuvant Chemotherapy: Feasibility Study. Journal of Clinical Medicine. 2021; 10(14):3149.
https://doi.org/10.3390/jcm10143149
Chicago/Turabian Style
Kurylcio, Andrzej, Zuzanna Pelc, Magdalena Skórzewska, Karol Rawicz-Pruszyński, Radosław Mlak, Katarzyna Gęca, Katarzyna Sędłak, Piotr Kurylcio, Teresa Małecka-Massalska, and Wojciech Polkowski.
2021. "Superparamagnetic Iron Oxide for Identifying Sentinel Lymph Node in Breast Cancer after Neoadjuvant Chemotherapy: Feasibility Study" Journal of Clinical Medicine 10, no. 14: 3149.
https://doi.org/10.3390/jcm10143149
APA Style
Kurylcio, A., Pelc, Z., Skórzewska, M., Rawicz-Pruszyński, K., Mlak, R., Gęca, K., Sędłak, K., Kurylcio, P., Małecka-Massalska, T., & Polkowski, W.
(2021). Superparamagnetic Iron Oxide for Identifying Sentinel Lymph Node in Breast Cancer after Neoadjuvant Chemotherapy: Feasibility Study. Journal of Clinical Medicine, 10(14), 3149.
https://doi.org/10.3390/jcm10143149
